The test, made by LabCorp, can be purchased online or in a store and allows people to self-collect their nasal swabs at home. They can then send their test samples to LabCorp for testing, and results are delivered by phone call, email or online portal. LabCorp didn’t say what the estimated turnaround time for results would be.
The test is for people aged 18 years and older.
“While many home collection kits can be prescribed with a simple online questionnaire, this newly authorized direct-to-consumer collection kit removes that step from the process, allowing anyone to collect their sample and send it to the lab for processing,” said Jeff Shuren, MD, director of the FDA’s Center for Devices and Radiological Health.
Read the FDA’s full news release here.
More articles on supply chain:
American Airlines to offer at-home COVID-19 tests for travelers
How dry ice makers are preparing for COVID-19 vaccine approval
FDA gives emergency approval to first at-home combination COVID-19 + flu test
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
